Search

Digital oral presentations: DOP Session 5 - Risks of disease, hazard of drugs (2020)

DOP37 Neoplastic lesions outside diseased area in inflammatory bowel disease patients: A national cohort study

DOP38 Prevalence of fatigue in a severe inflammatory bowel disease cohort highly exposed to biologics

DOP39 The first prospective, multicentre, randomised controlled trial on discontinuation of infliximab in ulcerative colitis in remission; endoscopic normalisation does not guarantee successful withdrawal

DOP40 Does levels of concerns and expectations predict IBD disease status?

DOP41 Low-grade dysplasia prognosis and predictive factors for advanced neoplasia progression in the 21st century: A large multi-centre retrospective cohort study

DOP42 Impact of discontinuing thiopurines at anti-TNF initiation in inflammatory bowel disease: A nationwide Danish cohort study

DOP43 The risk of extra-intestinal cancer in inflammatory bowel disease (IBD): A systematic review and meta-analysis of population-based cohort studies

DOP44 Cancer risk in a high-incidence inflammatory bowel disease population: a Faroese IBD cohort study

DOP45 Increased prevalence but not incidence of myocardial infarction and stroke in patients with inflammatory bowel diseases in Quebec in 1996–2015